NCT06790030 Does Self-Efficacy at the Start of Treatment Influence Treatment Outcome in Patients With EDs?
| NCT ID | NCT06790030 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Altrecht |
| Condition | Eating Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-03-28 |
| Primary Completion | 2025-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2023-03-28 with a primary completion date of 2025-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to contribute to the improvement of treatment for eating disorders, by identifying factors that might positively affect treatment outcome. The main questions it aims to answer are: 1. Do higher levels of self-efficacy positively predict a more positive treatment outcome? 2. Does self-efficacy in itself improve during treatment? 3. Do autonomous motivation, self-esteem and self-efficacy correlate? These factors will be measured in patients being treated for their eating disorders with Cognitive Behavior Therapy - Ten (CBT-T). Researchers will administer questionnaires at start, session four and end of treatment. Participants will: 1. Receive their treatment as usual. 2. fill in questionnaires at the start of treatment, session 4 and end of treatment.
Eligibility Criteria
Patients are eligible for participation when they meet the following inclusion criteria: * Participants must be 18 years or older * Having an eating disorder diagnosed according to the Diagnostic Statistical Manual (DSM-5) * Starting CBT-T treatment Exclusion criteria * Intellectual disability according to the Diagnostic Statistical Manual (DSM-5) or an IQ below 80 * Inability to speak or read Dutch * Patients treated under a legal act
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06790030 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Eating Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06790030 currently recruiting?
Yes, NCT06790030 is actively recruiting participants. Contact the research team at a.jansingh@altrecht.nl for enrollment information.
Where is the NCT06790030 trial being conducted?
This trial is being conducted at Zeist, Netherlands.
Who is sponsoring the NCT06790030 clinical trial?
NCT06790030 is sponsored by Altrecht. The trial plans to enroll 50 participants.